Propofol 2% in critically ill patients: effect on lipids

Area of Science:

• Critical Care Medicine
• Clinical Chemistry
• Pharmacology

Background:

• Critically ill patients often receive prolonged sedation, with propofol being a common agent.
• Understanding the metabolic effects of propofol, particularly on lipid profiles, is crucial for patient management.
• The acute-phase response in critical illness can influence various biochemical markers, including lipids.

Purpose of the Study:

• To evaluate the impact of a 50-hour continuous infusion of 2% propofol on triglyceride, cholesterol, and high-density lipoprotein (HDL) levels in intensive care unit (ICU) patients.
• To explore potential correlations between lipid concentrations, propofol consumption, patient demographics, severity scores, and inflammatory markers.

Main Methods:

• A prospective clinical study involving 30 adult, ventilated ICU patients requiring sedation for over 48 hours.
• Lipid profiles (triglyceride, cholesterol, HDL) were measured over a 50-hour period during propofol infusion.
• Inflammatory markers including tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and C-reactive protein (CRP) were also assessed.

Main Results:

• Median cholesterol and HDL concentrations remained low throughout the study. Peak triglyceride levels exceeded 3 mmol/L in seven patients, with a maximum of 4.83 mmol/L.
• No significant statistical difference in lipid concentrations was observed between the first and second day of infusion, though a trend towards increasing triglycerides was noted.
• A direct correlation was found between peak triglyceride and C-reactive protein levels, and an inverse correlation between cholesterol and C-reactive protein. No relationship was observed between cytokine levels and plasma triglycerides.

Conclusions:

• Continuous 50-hour propofol infusion in critically ill patients did not lead to a significant increase in triglyceride concentrations.
• Low mean cholesterol and HDL levels persisted during the study. The observed lipid alterations may be partly attributed to the acute-phase response in critically ill patients.
• The findings suggest that while propofol itself may not drastically alter lipid profiles, the patient's inflammatory state plays a significant role in lipid metabolism during critical illness.